Post-earnings recap
Reported
Thu, Jan 28, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's strong EPS performance indicates better-than-expected profitability, which likely contributed to the stock's modest increase of 0.87%. The lack of revenue data and guidance may leave some investors cautious, but management's positive tone suggests confidence in future operations. Overall, the results reflect the company's ability to navigate current market challenges effectively.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.41 | N/A | +15.29% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting resilience in their operations. They emphasized a commitment to innovation and customer service.
We are pleased with our performance this quarter despite the ongoing challenges.
Our focus remains on innovation and meeting customer needs.